- ABT +0.11%
The Art of Valuation: Discovering Abbott Laboratories's Intrinsic Value
Yahoo Finance · 1 week ago
Open | 112.31 |
High | 112.93 |
Low | 112.10 |
Mkt. Cap | 196.14B |
P/E (TTM) | 35.56 |
Div & Yield | 2.20 & 1.95% |
Prev. Close | 112.61 |
52 Wk. Low | 89.67 |
52 Wk. High | 121.64 |
Related stocks
American global health care and medical device products company
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Green Oaks, Illinois, United States. Wikipedia
(USD) | Q2 2024 | Y/Y |
---|---|---|
Revenue | 10.38B | 4.00% ▲ |
Net Income | 1.3B | 5.30% ▼ |
Diluted EPS | 1.14 | 5.10% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q4 2023 | $1.20 | - |
Q3 2023 | $1.10 | $1.14 |
Q1 2024 | $0.95 | $0.98 |
S&P FuturesES=F | 5,815.50+11.00 (+0.19%) |
Dow FuturesYM=F | 42,646.00+91.00 (+0.21%) |
Nasdaq FuturesNQ=F | 20,387.00+40.75 (+0.20%) |
402.40-12.17% | |
901.44-0.77% | |
50.12+0.34% |